Insights On Drug Development

  1. Optimizing Bispecific Antibody Expression Via Multi-Omics Analysis And Vector Redesign 12/17/2025

    Discover how diagnosing ribosome pausing sites and optimizing codon usage dramatically improves bispecific antibody titers, turning difficult-to-express candidates into viable therapeutics.

  2. Doubling Up For Speed In Biomanufacturing 12/12/2025

    Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.

  3. CDMOs - Key Collaborators In Streamlining Drug Development 12/12/2025

    Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.

  4. Is Your Biologics CDMO Transparent? 12/12/2025

    Transparency and collaboration with a CDMO are vital for reducing risk and protecting IP. Discover four essential practices, from clear communication to IP safeguards, that help build trust.

  5. Digital Innovation And Sustainability Are Redefining Biomanufacturing 12/8/2025

    Next Generation Manufacturing (NGM) integrates advanced process design, digital innovation, and strategic facility planning to facilitate agile, efficient, and sustainable biopharmaceutical production.

  6. Advancing Drug Development Through Expertise In Energetic Chemistry 12/5/2025

    Overcoming development complexity requires robust process safety. Solutions can safely scale challenging reactions, like click chemistry and cryogenic organometallics, improving efficiency and results.

  7. How To Capture Growth In The Expanding Metabolic Drug Market 12/2/2025

    Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.

  8. Model-Driven Genetic Design And Bioprocess Optimization Across Modalities 12/2/2025

    Traditional biomanufacturing relies too heavily on trial and error. By integrating AI and mechanistic models into early design, developers can overcome productivity limits and accelerate timelines for complex therapeutic modalities.

  9. Flexible And Scalable Capacity That Grows With You 11/24/2025

    Explore flexible, globally compliant aseptic fill/finish services spanning clinical to commercial scales. Learn about handling various molecule types and dosage forms, supported by integrated development and regulatory services.

  10. Developments In OSD Manufacturing: What Biotechs Need To Know 11/24/2025

    Oral solid dose (OSD) manufacturing advances address poor solubility and HPAPI handling through innovations like advanced formulation, enhanced containment, and flexible digitalized suites.